PF
BLRX

Phoenix Financial’s BioLineRX BLRX Stock Holding History

Phoenix Financial’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-643
Closed -$65K – 199
2019
Q3 		$65K Buy
+643
New +$89.2K ﹤0.01% 188

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Phoenix Financial's BLRX Position: Q4 2019 in Review

Phoenix Financial sold out of BioLineRX (BLRX) in Q4 2019, closing a stake of 643 shares — an estimated $65K sold.

Phoenix Financial first reported a position in BLRX in Q3 2019 and held it in 1 quarter. The position peaked at $65K in Q3 2019. 12 funds tracked by Wall St. Rank hold BLRX as of Q4 2019.

  • Phoenix Financial reported no remaining BioLineRX position as of Q4 2019 after selling out during the quarter.
  • Phoenix Financial sold 643 BioLineRX shares in Q4 2019, an estimated $65K.
  • Phoenix Financial first reported a position in BioLineRX in Q3 2019 and held it in 1 quarter.
  • Phoenix Financial's BioLineRX position peaked at $65K in Q3 2019.
  • 12 funds tracked by Wall St. Rank held BioLineRX as of Q4 2019.

Based on Phoenix Financial's 13F filing for Q4 2019, filed 18 Feb 2020.